| scholarly article | Q13442814 |
| P2093 | author name string | Charles P Lin | |
| Nilesh M Dagia | |||
| Joel A Spencer | |||
| Robert Sackstein | |||
| Derek W Cain | |||
| Roland Wohlgemuth | |||
| Jasmeen S Merzaban | |||
| P2860 | cites work | Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue | Q24564382 |
| CD44 is a major E-selectin ligand on human hematopoietic progenitor cells | Q24679247 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Pluripotency of mesenchymal stem cells derived from adult marrow | Q29617959 | ||
| In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment | Q30484167 | ||
| Second harmonic generation imaging of endogenous structural proteins | Q31126779 | ||
| Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone | Q34066339 | ||
| The small GTPase Rap1 is required for Mn(2+)- and antibody-induced LFA-1- and VLA-4-mediated cell adhesion | Q34143854 | ||
| How do stem cells find their way home? | Q34418463 | ||
| A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells | Q35578307 | ||
| Mesenchymal stem cells and their potential as cardiac therapeutics | Q35830869 | ||
| Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects | Q36184145 | ||
| The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. | Q36235481 | ||
| The lymphocyte homing receptors: gatekeepers of the multistep paradigm | Q36282864 | ||
| Mechanism and specificity of human alpha-1,3-fucosyltransferase V. | Q36816396 | ||
| CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. | Q37548676 | ||
| Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells | Q38361707 | ||
| Real time analysis of the affinity regulation of alpha 4-integrin. The physiologically activated receptor is intermediate in affinity between resting and Mn(2+) or antibody activation | Q40773758 | ||
| Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2. | Q40946081 | ||
| Dual control by divalent cations and mitogenic cytokines of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity expressed by human hemopoietic cells. | Q40999880 | ||
| The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. | Q43599448 | ||
| Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow | Q44997562 | ||
| Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow | Q45059080 | ||
| Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro | Q45180712 | ||
| HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke | Q48446087 | ||
| Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts | Q73791469 | ||
| Total body irradiation causes profound changes in endothelial traffic molecules for hematopoietic progenitor cell recruitment to bone marrow | Q74097992 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 181-7 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone | |
| P478 | volume | 14 |
| Q39152658 | A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells |
| Q60908104 | A Single-Step Chemoenzymatic Reaction for the Construction of Antibody-Cell Conjugates |
| Q50946912 | A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis. |
| Q37457516 | A cell rolling cytometer reveals the correlation between mesenchymal stem cell dynamic adhesion and differentiation state. |
| Q90651378 | A glucose/O2 fuel cell-based self-powered biosensor for probing a drug delivery model with self-diagnosis and self-evaluation |
| Q39928484 | A novel mTOR inhibitor is efficacious in a murine model of colitis |
| Q39298233 | A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion |
| Q27321219 | A small-molecule screen for enhanced homing of systemically infused cells |
| Q38614733 | Adhesion receptors involved in HSC and early-B cell interactions with bone marrow microenvironment |
| Q94018218 | Advances in Single-cell Tracking of Mesenchymal Stem Cells (MSCs) During Musculoskeletal Regeneration |
| Q41058896 | Advances in cell surface glycoengineering reveal biological function |
| Q91811850 | Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications |
| Q35172452 | Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells |
| Q33696336 | Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc |
| Q64106032 | Bacterial glycosyltransferase-mediated cell-surface chemoenzymatic glycan modification |
| Q28069791 | Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells |
| Q34713778 | Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models |
| Q47358282 | Bioengineering and Imaging Research Opportunities Workshop V: a white paper on imaging and characterizing structure and function in native and engineered tissues |
| Q43160709 | Bioengineering and imaging research opportunities workshop V: summary of findings on imaging and characterizing structure and function in native and engineered tissues |
| Q35611763 | Biological properties of extracellular vesicles and their physiological functions. |
| Q33777543 | Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury |
| Q30645221 | Biphasic monopolar electrical stimulation induces rapid and directed galvanotaxis in adult subependymal neural precursors |
| Q92995104 | Blocked O-GlcNAc cycling disrupts mouse hematopoeitic stem cell maintenance and early T cell development |
| Q35777526 | Body Management: Mesenchymal Stem Cells Control the Internal Regenerator |
| Q34553368 | Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes |
| Q93112223 | Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis |
| Q38169643 | Bringing natural killer cells to the clinic: ex vivo manipulation |
| Q39027200 | CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect |
| Q41145573 | CD15 expression in human myeloid cell differentiation is regulated by sialidase activity |
| Q35376738 | CD44 and HCELL: preventing hematogenous metastasis at step 1. |
| Q48029838 | CD44 fucosylation on mesenchymal stem cell enhances homing and macrophage polarization in ischemic kidney injury |
| Q92591194 | CD44 mediates stem cell mobilization to damaged lung via its novel transcriptional targets, Cortactin and Survivin |
| Q54339513 | Can magnetic targeting of magnetically labeled circulating cells optimize intramyocardial cell retention? |
| Q61866284 | Cell Surface Engineering to Control Cellular Interactions |
| Q38924531 | Cell carriers for oncolytic viruses: current challenges and future directions |
| Q39178313 | Cell membrane-derived nanomaterials for biomedical applications |
| Q35570010 | Cell sources for bone regeneration: the good, the bad, and the ugly (but promising). |
| Q36251782 | Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis |
| Q30683188 | Cell surface glycoengineering improves selectin-mediated adhesion of mesenchymal stem cells (MSCs) and cardiosphere-derived cells (CDCs): Pilot validation in porcine ischemia-reperfusion model. |
| Q39524013 | Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells |
| Q38288595 | Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology. |
| Q36811051 | Chemical probing of glycans in cells and organisms |
| Q35170330 | Chemistry and material science at the cell surface. |
| Q37871512 | Circulating osteogenic cells: implications for injury, repair, and regeneration |
| Q41194503 | Combination stem cell therapy for heart failure |
| Q91686329 | Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells |
| Q34238869 | Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis. |
| Q26782203 | Complement activation in the context of stem cells and tissue repair |
| Q41851257 | Comprehensive Screening of Cell Surface Markers Expressed by Adult-Derived Human Liver Stem/Progenitor Cells Harvested at Passage 5: Potential Implications for Engraftment. |
| Q58804653 | Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise |
| Q47762656 | Concise Review: Musculoskeletal Stem Cells to Treat Age-Related Osteoporosis. |
| Q37200221 | Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. |
| Q92037568 | Convergence of Cell Pharmacology and Drug Delivery |
| Q92970977 | Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus |
| Q50253475 | Could fetal fluid and membranes be an alternative source for mesenchymal stem cells (MSCs) in the feline species? A preliminary study |
| Q38998703 | Current challenges for the targeted delivery and molecular imaging of stem cells in animal models |
| Q37870827 | Death and inflammation following somatic cell transplantation |
| Q39245333 | Definition of molecular determinants of prostate cancer cell bone extravasation |
| Q34432396 | Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice |
| Q38027408 | Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology. |
| Q38436187 | Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell |
| Q33858275 | Difference between biomarkers of tibial bone marrow and adipose tissue |
| Q42917963 | Directing Stem Cell Trafficking via GPS |
| Q88204903 | Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells |
| Q89840858 | Dual-Functionalized MSCs that Express CX3CR1 and IL-25 Exhibit Enhanced Therapeutic Effects on Inflammatory Bowel Disease |
| Q50197234 | E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy |
| Q50627263 | Effect of mesenchymal stem cells and galantamine nanoparticles in rat model of Alzheimer's disease. |
| Q42574753 | Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis |
| Q36014258 | Effects of hypoxia and its relationship with apoptosis, stem cells, and angiogenesis on the thymus of children with congenital heart defects: a morphological and immunohistochemical study |
| Q35580471 | Electrically guiding migration of human induced pluripotent stem cells. |
| Q34728538 | Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice |
| Q34573227 | Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells |
| Q50074949 | Engineered Glycocalyx Regulates Stem Cell Proliferation in Murine Crypt Organoids. |
| Q35623682 | Engineered cell homing |
| Q48474574 | Engineered mesenchymal stem cells with enhanced tropism and paracrine secretion of cytokines and growth factors to treat traumatic brain injury |
| Q40734038 | Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting |
| Q93005872 | Engineering Cell Surfaces with Polyelectrolyte Materials for Translational Applications |
| Q35911411 | Engineering cellular trafficking via glycosyltransferase-programmed stereosubstitution |
| Q27026414 | Engineering mesenchymal stem cells for regenerative medicine and drug delivery |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q35865058 | Enhanced Healing of Rat Calvarial Bone Defects with Hypoxic Conditioned Medium from Mesenchymal Stem Cells through Increased Endogenous Stem Cell Migration via Regulation of ICAM-1 Targeted-microRNA-221 |
| Q35142623 | Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials |
| Q92921849 | Eph/ephrin Signaling and Biology of Mesenchymal Stromal/Stem Cells |
| Q91503235 | Exploiting metabolic glycoengineering to advance healthcare |
| Q47840988 | Expression and Characterization of Human β-1, 4-Galactosyltransferase 1 (β4GalT1) Using Silkworm-Baculovirus Expression System |
| Q42168549 | Expression of CD44 standard form and variant isoforms in human bone marrow stromal cells |
| Q38225141 | Extracellular galectin-3 in tumor progression and metastasis. |
| Q35962339 | Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice. |
| Q64931629 | FGF2 Induces Migration of Human Bone Marrow Stromal Cells by Increasing Core Fucosylations on N-Glycans of Integrins. |
| Q33768071 | Facile synthetic route for surface-functionalized magnetic nanoparticles: cell labeling and magnetic resonance imaging studies |
| Q38133556 | From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? |
| Q34375340 | Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment |
| Q37154043 | Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic stem cells |
| Q36843250 | Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology |
| Q37672292 | Generation of tissue-specific cells from MSC does not require fusion or donor-to-host mitochondrial/membrane transfer |
| Q26765063 | Glycan Engineering for Cell and Developmental Biology |
| Q33998871 | Glycocalyx remodeling with proteoglycan mimetics promotes neural specification in embryonic stem cells |
| Q41657642 | Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells |
| Q35850785 | Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration |
| Q39911635 | Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage |
| Q37349468 | Glycosylation in immune cell trafficking |
| Q55639950 | Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis. |
| Q28251644 | Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration |
| Q27027997 | Glycotherapy: new advances inspire a reemergence of glycans in medicine |
| Q35660316 | HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice |
| Q37730269 | HGF/c-Met signaling mediated mesenchymal stem cell-induced liver recovery in intestinal ischemia reperfusion model |
| Q37424307 | Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats |
| Q35011205 | Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells |
| Q50496881 | Highly Efficient Synthesis of Multiantennary Bisected N-glycans Based on Imidates. |
| Q37788681 | Homing Pathways of Mesenchymal Stromal Cells (MSCs) and Their Role in Clinical Applications |
| Q26750318 | Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? |
| Q37867955 | Homing of Mesenchymal Stem Cells |
| Q30571926 | Homing of neural stem cells from the venous compartment into a brain infarct does not involve conventional interactions with vascular endothelium |
| Q34576397 | Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies |
| Q30559315 | Human fucosyltransferase 6 enables prostate cancer metastasis to bone |
| Q83666745 | Human mesenchymal stem cells are recruited to injured liver in a β1-integrin and CD44 dependent manner |
| Q38628097 | Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation. |
| Q38073724 | Hypotheses on the evolution of hyaluronan: a highly ironic acid |
| Q41995599 | Identification and isolation of small CD44-negative mesenchymal stem/progenitor cells from human bone marrow using elutriation and polychromatic flow cytometry |
| Q37575552 | Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45. |
| Q41975016 | Identification of cytokines involved in hepatic differentiation of mBM-MSCs under liver-injury conditions |
| Q33960755 | Imaging and photodynamic therapy: mechanisms, monitoring, and optimization |
| Q37492370 | Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes |
| Q36470354 | Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells |
| Q43885229 | Impact of ERβ and CD44 expression on the prognosis of patients with stage II colon cancer |
| Q42706941 | Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications |
| Q26825202 | Implication of indolamine 2,3 dioxygenase in the tolerance toward fetuses, tumors, and allografts |
| Q59132146 | Improving Immunotherapy Through Glycodesign |
| Q48693282 | In vivo tracking and fate of intra-articularly injected superparamagnetic iron oxide particle-labeled multipotent stromal cells in an ovine model of osteoarthritis |
| Q38921024 | Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells |
| Q91683057 | Inherited thrombocytopenia associated with mutation of UDP-galactose-4-epimerase (GALE) |
| Q24324389 | Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels |
| Q27329981 | Intravital imaging of mesenchymal stem cell trafficking and association with platelets and neutrophils. |
| Q53457714 | Isolation and characterization of equine amniotic fluid-derived multipotent stem cells |
| Q36958907 | Isolation and characterization of equine amniotic membrane-derived mesenchymal stem cells |
| Q36055845 | Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy |
| Q89241443 | Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration |
| Q39356606 | MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation |
| Q37290930 | Mammalian glycosylation in immunity |
| Q42912088 | Matrix remodeling as stem cell recruitment event: A novel in vitro model for homing of human bone marrow stromal cells to the site of injury shows crucial role of extracellular collagen matrix |
| Q37941478 | Mechanism of arterial remodeling in chronic allograft vasculopathy |
| Q39217065 | Mechanobiology of mesenchymal stem cells: Which interest for cell-based treatment? |
| Q37615286 | Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? |
| Q48203084 | Mesenchymal Stem Cell Deformability and Implications for Microvascular Sequestration |
| Q57170076 | Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy |
| Q64274626 | Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement |
| Q38206110 | Mesenchymal stem cell priming: fine-tuning adhesion and function |
| Q34154534 | Mesenchymal stem cell therapy of intestinal disease: are their effects systemic or localized? |
| Q33898653 | Mesenchymal stem cell therapy: Two steps forward, one step back |
| Q36546424 | Mesenchymal stem cell-based therapy |
| Q30690412 | Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis. |
| Q27317423 | Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear |
| Q37762880 | Mesenchymal stem cells: Mechanisms of immunomodulation and homing |
| Q39441246 | Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors |
| Q37873299 | Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? |
| Q38902441 | Metabolic Glycoengineering with N-Acyl Side Chain Modified Mannosamines |
| Q36964235 | Metabolic glycoengineering of mesenchymal stromal cells with N-propanoylmannosamine |
| Q28394526 | Metastasis suppressor genes at the interface between the environment and tumor cell growth |
| Q34648929 | Metastasis suppressors and the tumor microenvironment |
| Q30503541 | Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions. |
| Q48324115 | Modulating Cell-Surface Receptor Signaling and Ion Channel Functions by In Situ Glycan Editing. |
| Q92190625 | Modulating the distribution and fate of exogenously delivered MSCs to enhance therapeutic potential: knowns and unknowns |
| Q58761454 | Multiple Roles of Glycans in Hematological Malignancies |
| Q34791234 | Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases |
| Q37421286 | Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. |
| Q54298113 | Myeloid-specific expression of Stat3C results in conversion of bone marrow mesenchymal stem cells into alveolar type II epithelial cells in the lung. |
| Q39564643 | Nanoparticulate cellular patches for cell-mediated tumoritropic delivery |
| Q33864915 | Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia. |
| Q42520024 | Nanotopographical cues augment mesenchymal differentiation of human embryonic stem cells. |
| Q30361288 | New Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia |
| Q38058023 | Nichotherapy for stem cells: there goes the neighborhood |
| Q53372276 | Nicotinamide Facilitates Mesenchymal Stem Cell Differentiation Into Insulin-Producing Cells and Homing to Pancreas in Diabetic Mice. |
| Q89777786 | Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44 |
| Q42366194 | Osteopontin activates mesenchymal stem cells to repair skin wound |
| Q37034680 | Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation |
| Q27310708 | Pharmacological inhibition of caspase and calpain proteases: a novel strategy to enhance the homing responses of cord blood HSPCs during expansion |
| Q49586288 | Polyvalent Display of Biomolecules on Live Cells |
| Q42252561 | Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein |
| Q26824479 | Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells |
| Q42594348 | Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. |
| Q35276443 | Protein glycoengineering enabled by the versatile synthesis of aminooxy glycans and the genetically encoded aldehyde tag |
| Q26850495 | Proteins and small molecules for cellular regenerative medicine |
| Q99415670 | Pulsed focused ultrasound enhances the therapeutic effect of mesenchymal stromal cell-derived extracellular vesicles in acute kidney injury |
| Q35036107 | Quantification of Mesenchymal Stem Cell (MSC) delivery to a target site using in vivo confocal microscopy |
| Q27314509 | Rapidly self-renewing human multipotent marrow stromal cells (hMSC) express sialyl Lewis X and actively adhere to arterial endothelium in a chick embryo model system |
| Q30418365 | Rare cell isolation and analysis in microfluidics |
| Q37063821 | Realizing the Promise of Chemical Glycobiology |
| Q37310986 | Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver |
| Q36831102 | Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis |
| Q38075424 | Redox regulation in stem-like cancer cells by CD44 variant isoforms. |
| Q37890947 | Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms |
| Q37622670 | Remodeling of marrow hematopoietic stem and progenitor cells by non-self ST6Gal-1 sialyltransferase |
| Q37317858 | Role of endothelial N-glycan mannose residues in monocyte recruitment during atherogenesis. |
| Q34590239 | Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature |
| Q64094872 | Selectins and Immune Cells in Acute Myocardial Infarction and Post-infarction Ventricular Remodeling: Pathophysiology and Novel Treatments |
| Q41431556 | Spatiotemporal control of cell-cell reversible interactions using molecular engineering |
| Q39008870 | Stem Cells as a Promising Tool for the Restoration of Brain Neurovascular Unit and Angiogenic Orientation. |
| Q36004894 | Stem cell membrane engineering for cell rolling using peptide conjugation and tuning of cell-selectin interaction kinetics |
| Q37946242 | Stem cells: novel players in the treatment of erectile dysfunction |
| Q38845401 | Strategies for cell membrane functionalization. |
| Q38250679 | Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy |
| Q36204478 | Surface antigenic profiling of stem cells from human omentum fat in comparison with subcutaneous fat and bone marrow |
| Q46307082 | Surface glycan pattern of canine, equine, and ovine bone marrow-derived mesenchymal stem cells |
| Q92181273 | Synthetic glycoscapes: addressing the structural and functional complexity of the glycocalyx |
| Q36808571 | Systemic Mesenchymal Stromal Cell Transplantation Prevents Functional Bone Loss in a Mouse Model of Age-Related Osteoporosis |
| Q38873974 | T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy. |
| Q24601626 | Targeting improves MSC treatment of inflammatory bowel disease |
| Q30488087 | Targeting mesenchymal stem cells to activated endothelial cells |
| Q61449162 | The First Step in Adoptive Cell Immunotherapeutics: Assuring Cell Delivery via Glycoengineering |
| Q24628178 | The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives |
| Q108768848 | The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans |
| Q37559776 | The engagement of selectins and their ligands in colorectal cancer liver metastases |
| Q36054671 | The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis |
| Q38246646 | The role of pericyte detachment in vascular rarefaction |
| Q37531597 | The role of stromal stem cells in tissue regeneration and wound repair. |
| Q90213463 | The role of ultrasound in enhancing mesenchymal stromal cell-based therapies |
| Q94541441 | The sialyltransferase ST3Gal-IV guides murine T-cell progenitors to the thymus |
| Q34869707 | The use of surface immobilization of P-selectin glycoprotein ligand-1 on mesenchymal stem cells to facilitate selectin mediated cell tethering and rolling |
| Q38213836 | Therapeutic cell carriers: a potential road to cure glioma |
| Q36092153 | Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth |
| Q64012586 | Tissue repair and regeneration with endogenous stem cells |
| Q38706553 | Towards the next generation of biomedicines by site-selective conjugation |
| Q36971659 | Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue |
| Q35056447 | Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft |
| Q37627675 | Ultrasound-Mediated Mesenchymal Stem Cells Transfection as a Targeted Cancer Therapy Platform |
| Q37957027 | Understanding glycomechanics using mathematical modeling: a review of current approaches to simulate cellular glycosylation reaction networks. |
| Q38909903 | Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells. |
| Q36540585 | Use of novel mutant galactosyltransferase for the bioconjugation of terminal N-acetylglucosamine (GlcNAc) residues on live cell surface |
| Q30548207 | mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. |
Search more.